Provectus Biopharmaceuticals Inc Sustainability Reports
Provectus Biopharmaceuticals, Inc. is a clinical-stage biotechnology company developing a pipeline of immunotherapy medicines based on rose bengal sodium. Its clinical programs span oncology, dermatology, ophthalmology, and other proof-of-concept programs.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 549300PIIESQMJOOJG14
FIGI: BBG001SKFZ53
6 reports from 2007 to 2024
